Given the similarities between the underlying fibroblast-driven fibrosis in IPF and in RIPF, it is therefore not surprising studies have shown that mTOR inhibition is also effective at suppressing the fibrotic process. Here, MTOR is linked to idiopathic pulmonary fibrosis.